Diagnostics Inc expected to post a loss of 22 cents a share - Earnings Preview

Co-Diagnostics

08/05/2023 12:45

* Co-Diagnostics Inc  CODX.OQ   CODX.O  is expected to show
a fall
in quarterly revenue when it reports  results on May 11. 
    * The Salt Lake City Utah-based  company is expected to
report  a
95.2% decrease in revenue to $1.1 million from $22.7 million a
year ago, according to the mean estimate from 2 analysts, based
on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Co-Diagnostics Inc
is for
a loss of 22 cents per share. 
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for
Co-Diagnostics
Inc is $4​, above​ its last closing price of $1.38. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Dec. 31 2022  -0.15       -0.15      -0.68     Missed  -353.3
 Sep. 30 2022  -0.06       -0.04      -0.04     Met     5.9
 Jun. 30 2022  0.15        0.10       -0.08     Missed  -182.8
                                                        ​
 Mar. 31 2022  0.17        0.17       0.34      Beat    96.2
 ​​Dec.        0.12        0.12       0.25      Beat    108.3
 31 2021                                                
 Sep. 30 2021  0.20        0.21       0.38      Beat    83.9​
 Jun. 30 2021  0.22        0.22       0.33      Beat    50
 Mar. 31 2021  0.22        0.22       0.26      Beat    18.2
 This summary was machine generated May 8 at 11:45 GMT.  All
figures in US dollars  unless otherwise stated